1.Comparison of Facial Nerve Paralysis in Adults and Children.
Chang Il CHA ; Chang Kee HONG ; Moon Suh PARK ; Seung Geun YEO
Yonsei Medical Journal 2008;49(5):725-734
PURPOSE: Facial nerve injury can occur in the regions ranging from the cerebral cortex to the motor end plate in the face, and from many causes including trauma, viral infection, and idiopathic factors. Facial nerve paralysis in children, however, may differ from that in adults. We, therefore, evaluated its etiology and recovery rate in children and adults. MATERIALS AND METHODS: We retrospectively evaluated the records of 975 patients, ranging in age from 0 to 88 years, who displayed facial palsy at Kyung Hee Medical Center between January 1986 and July 2005. RESULTS: The most frequent causes of facial palsy in adults were Bell's palsy (54.9%), infection (26.8%), trauma (5.9%), iatrogenic (2.0%), and tumors (1.8%), whereas the most frequent causes of facial palsy in children were Bell's palsy (66.2%), infection (14.6%), trauma (13.4%), birth trauma (3.2%), and leukemia (1.3%). Recovery rates in adults were 91.4% for Bell's palsy, 89.0% for infection, and 64.3% for trauma, whereas recovery rates in children were 93.1% for Bell's palsy, 90.9% for infection, and 42.9% for trauma. CONCLUSION: These results show that causes of facial palsy are similar in adults and children, and recovery rates in adults and children are not significantly different.
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Child
;
Child, Preschool
;
Facial Paralysis/*etiology/*rehabilitation/therapy
;
Female
;
Humans
;
Infant
;
Infant, Newborn
;
Male
;
Middle Aged
;
Recovery of Function
;
Retrospective Studies
;
Treatment Outcome
2.Comparison Between TKR with Tourniqeut and Injected Diluted Adrenaline without Tourniqeut.
Sung Won SOHN ; Jin Uck PARK ; Kyung Kee YEO ; Jin Mo KIM
Journal of the Korean Knee Society 2005;17(1):53-57
PURPOSE: To assess clinical difference between total knee replacement (TKR) performed with tourniquet and diluted adrenine infiltration without tourniquet. MATERIALS AND METHODS: We analyzed the postoperative transfusion amount, intraoperative blood loss, operation time, range of motion and postoperative thigh pain in 60 cases. 30 cases (group I) were performed TKR with tourniquet and the others (group II) were performed TKR using diluted adrenaline (2.5mg of 1:1000 epinephrine diluted in 500 ml of normal saline) infiltration without tourniquet. Closed suction drainage was not used in all patients. RESULTS: In gruop I, the intraoperative blood loss was average 407.6 ml, pre- and postoperative hemoglobin average 12.6 and 9.4 g/dl, postoperative transfusion average 1.83 unit, operative time average 116.5 minutes and range of motion (at preoperative, at 7days and 6 weeks after the operation) average 116.3 degrees, 90.7degrees and 103.4degrees. In group II, the intraoperative blood loss was average 398.2 ml, pre- and postoperative hemoglobin average 13.1 and 9.7 g/dl, postoperative transfusion amount average 1.76 unit, operative time average 118.3 minutes and range of motion average 113.6 degrees, 89.2 degrees, and 105.7degrees. But average postoperative thigh pain score was significantly higher in group I (average 3.7) than group II (average 0.9). CONCLUSION: There was no significant difference in intraoperative blood loss, pre- and postoperative hemoglobin, postoperative transfusion amount, operative time and range of motion between the two groups. But we could decrease the thigh pain after TKR, not using the tourniquet.
Arthroplasty, Replacement, Knee
;
Epinephrine*
;
Humans
;
Operative Time
;
Range of Motion, Articular
;
Suction
;
Thigh
;
Tourniquets
3.Local Immunity of Pediatric Adenoid with Allergic Rhinitis & Sinusitis.
Seung Geun YEO ; Dong Choon PARK ; Chang Kee HONG ; Ju Sup SIM ; Chang Il CHA
Immune Network 2007;7(2):87-94
BACKGROUND: Chronic rhino-sinusitis and persistent allergic rhinitis is often cited as risk factor for developing adenoid hypertrophy or adenoiditis, but this relationship has not been studied extensively. In this study, we evaluated the mucosal barrier, squamous changes of ciliated epithelium, IgA secretion and BCL-6 expression in adenoids, and adenoid size. METHODS: Six children with allergic rhinitis and sinusitis, nine children with only allergic rhinitis, nine children with only sinusitis and six children without any history of allergic rhinitis and sinusitis were enrolled. H-E stain of adenoid for squamous metaplasia, immunohistochemical study of adenoid for IgA and BCL-6, cytokeratin stain for evaluation of mucosal barrier and lateral view X-ray for adenoid size were performed. ANOVA test was used in the analysis and data showing p value of less than 0.05 were considered significant. RESULTS: The number of ciliated cells had tendency to be decreased and squamous metaplasia had tendency to be increased in three experimental groups (p>0.05). Deterioration of mucosal barrier had tendency to be detected in three experimental groups than control group (p>0.05). BCL-6 had tendency to be increased and IgA secretion had tendency to be decreased in three experimental groups (p>0.05). There is no difference in adenoid size between three experimental groups and control group. CONCLUSION: Despite the expectation that adenoid would be affectecd by allergic rhinitis and rhino-sinusitis, we found no evidence for influence of adenoid immunity.
Adenoids*
;
Child
;
Epithelium
;
Humans
;
Hypertrophy
;
Immunoglobulin A
;
Keratins
;
Metaplasia
;
Rhinitis*
;
Risk Factors
;
Sinusitis*
4.Prevention Effects of Graduated Compression Stockings and Intermittent Pneumatic Compression on Deep Vein Thrombosis in SICU Patients: Pilot Study.
Hwasoon KIM ; Ok Min CHO ; Ji Sun KIM ; Hai Ok JANG ; Yeo Kyeong KIM ; Seol Hee KIM ; Hyo Nam MIN ; Kyung Sun KWAK ; Kee Chun HONG ; Jang Yong KIM ; Joonho CHUNG
Journal of Korean Academy of Fundamental Nursing 2015;22(3):249-257
PURPOSE: The purpose of this pilot study was to investigate the effects of mechanical interventions for deep vein thrombosis (DVT) prophylaxis in surgical intensive care unit (SICU) patients. METHODS: The participants were assigned to the intermittent pneumatic compression (IPC) and graduated compression stocking (GCS) intervention. Patients who met the criteria were selected for comparison from our previous study. Data for 140 patients were included in the final analysis. RESULTS: The mean age was 57.5 (+/-15.7) and 61.4% were men. About forty-seven percent of the participants were 61 years or over. In the second duplex scan, 3, 2 and 1 critically ill patients developed deep vein thrombosis in the control, GCS, and IPC groups, respectively. Incidences of DVT were 6.0%, 5.0%, and 2.0% for the control, GCS, and IPC groups, respectively. This difference was not significant. Relative risks of no intervention were 3.0 and 1.2 compared with IPC and GCS application. There were no significantly different variables among the three groups before the intervention except for diagnosis on admission. CONCLUSION: Although it may difficult to conclude that mechanical prophylaxis effectively prevents DVT among SICU patients because there was no statistical significance in this study, but incidence rates among the three groups differed greatly. The findings reveal that further study should be conducted with larger samples and randomized controlled trial for SICU patients.
Critical Care
;
Critical Illness
;
Diagnosis
;
Humans
;
Incidence
;
Critical Care
;
Intermittent Pneumatic Compression Devices
;
Male
;
Pilot Projects*
;
Stockings, Compression*
;
Venous Thrombosis*
5.Efficacy and Safety during the Combination Therapy of Imipramine and Desmopressin in Primary Monosymptomatic Nocturnal Enuresis.
Yong Hoon PARK ; Ji Hyun YEO ; Jung Youn CHOI ; Hyo Seok CHUNG ; Kyung Soo LEE ; Cheol Woo KO ; Kyo Sun KIM ; Kee Hyuk KIM ; Jung Soe KIM ; Mee Kyung NAMGOONG ; Young Seo PARK ; Ki Soo PAI ; Kee Hwan YOO ; Kyung Yil LEE ; Dae Yeol LEE ; Seung Joo LEE ; Oh Kyung LEE ; Jae Seung LEE ; Hong Jun LEE ; Seung Hee JUNG ; Woo Yeong CHUNG ; Tae Sun HA
Journal of the Korean Society of Pediatric Nephrology 2004;8(2):129-137
PURPOSE: Nocternal enuresis is a common disorder. Tricyclic antidepressant and desmopressin have been accepted pharmacological treatment for this disorder. We conducted a cooperative study to investigate the efficacy and adverse reactions of imipramine, desmopressin and combination treatment in children with primary monosymptomatic nocturnal enuresis(PMNE). METHODS: Data from a large multicenter study were analysed. In the period of 8 months in 2002, the study comprised of 168 children(78 boys and 90 girls, 5 to 15 years old) with PMNE for imipramine, desmopressin or combination treatment. Before treatment a history, physical examination and laboratory tests were performed and the children were observed for 2 weeks. Response rate, adverse reactions and enuresis episodes after stopping drug administration were evaluated after 12-weeks of imipramine, desmopressin or combination of both. RESULTS: After 4 weeks, the frequency of bed wetting in all treated patients decreased during treatment significantly. Even though a 30-50% reduction in the number of wet nights were 68.6%, 74.4% and 86.1% during 12 weeks treatment by imipramine, desmopressin and both of them respectively, there was no significant difference between them. The most common adverse reaction was decreased appetite from imipramine administration. But no serious drug-related adverse events were reported. CONCLUSION: Efficacy of the combination therapy of imipramine and desmopressin in PMNE appears not to be better than either drug alone. It is necessary to pay attention on account of adverse reactions during imipramine treatment even though imipramine and desmopressin were generally well tolerated.
Appetite
;
Child
;
Deamino Arginine Vasopressin*
;
Enuresis
;
Female
;
Humans
;
Imipramine*
;
Nocturnal Enuresis*
;
Physical Examination
6.A Case of Idiopathic Retroperitoneal Fibrosis with Acute Renal Failure.
Kyung Hae LEE ; Sang Woong HAN ; Yeo Wook YUN ; Joon Kwang WANG ; Sung Hyun PARK ; Ui Soon PARK ; Young Woong WON ; Young Ha OH ; Yong Wook PARK ; Choon Suhk KEE ; Ho Jung KIM
Korean Journal of Nephrology 2004;23(4):649-654
Retroperitoneal fibrosis is proliferation of fibrous tissue with inflammatory process in retroperitoneal cavity. It is relatively rare disease that has been reported less than 20 cases in Korea until now. Idiopathic type is more frequent but secondary type is increasing nowadays. Secondary causes include drugs, infections, and leakage of blood or urine, malignancies, connective tissue diseases, etc. Recent studies suggest the relationship between retroperitoneal fibrosis and autoimmunity to own vascular or lipoid tissue. It can cause compression and obstruction of ureter, abdominal aorta, hypertension and finally collapse of renal function. Surgical procedure and immunosuppressive therapy consist of mainstay of management. Corticosteroid therapy may reduce inflammation and reverse fibrosis. Retroperitoneal fibrosis is thought to have some reVersible components in early stage. Corticosteroid may be used as initial therapy but more studies should be performed. We report a case of idiopathic retroperitoneal fibrosis with acute renal failure improved with ureter stent insertion and steroid therapy.
Acute Kidney Injury*
;
Aorta, Abdominal
;
Autoimmunity
;
Connective Tissue Diseases
;
Fibrosis
;
Hypertension
;
Inflammation
;
Korea
;
Rare Diseases
;
Retroperitoneal Fibrosis*
;
Stents
;
Ureter
7.Cytochrome P450 2E1 Polymorphisms and Genetic Susceptibility to Cervical Cancer.
Jin Woo KIM ; Chun Geun LEE ; Yeo Won SOHN ; Hong Ki MIN ; Kyung Wook LEE ; Ryung Joo KWON ; Hyun Sook KHO ; Jin Woong SHIN ; Heung Kee KIM ; Tae Eung KIM ; Joon Mo LEE ; Sung Eun NAMKOONG
Journal of the Korean Cancer Association 1997;29(3):429-436
PURPOSE: Interindividual genetic differences in susceptibility to chemical carcinogens are one of the most important host factors in human cancer. The genetically determined differences in metabolism, related to cytochrome P450 (CYP450) genes have been reported to be associated with various cancer susceptibility. The present study was set up to establish the frequency of the polymorphic genotypes of two CYP450 (CYP2E1/PstI and CYP2E1/DraI) isozymes in Korea, to evaluate a possible increased incidence of the genotype associated with higher cervical cancer risks among Korean cervical cancer patients. MATERIALS AND METHODS: In this study, extracted DNAs from 228 cervical cancer patients and 360 normal healthy controls were analysed with the polymerase chain reaction-restriction fragment length polymosphism (PCR-RFLP) method. RESULTS: In the CYP 2E1 genotypes, detected by PstI or RsaI digestion, there were no statistically remarkable differences between the cervical cancer patients and control groups. And when the cervical cancer patients were divided into subgroups with respect to the age, the frequency of CYP 2E1/PstI polymorphisms in the cervical cancer patients under the 40 years old was not significantly higher compared to the controls or the patients above the 40 years old and, c1/c1 genotype was prominent in this type of polymorphism. The frequency of CYP 2E1/DraI polymorphisms in the cervical cancer patients was not significantly higher compared to the controls, and D/D genotype was prominent in this type of polymorphism. In cervical carcinoma, the polymorphic genotypes of CYP 2E1 were not correlated to other parameters including clinical stage, histological tumor type, and degree of differentiation. CONCLUSION: These results suggest that individuals carrying CYP 2E1/PstI (c1/c1) or CYP 2E1/DraI (D/D) alleles are not genetically susceptible to cervical cancer in Korea.
Adult
;
Alleles
;
Carcinogens
;
Cytochrome P-450 CYP2E1*
;
Cytochrome P-450 Enzyme System*
;
Cytochromes*
;
Digestion
;
DNA
;
Genetic Predisposition to Disease*
;
Genotype
;
Humans
;
Incidence
;
Isoenzymes
;
Korea
;
Metabolism
;
Uterine Cervical Neoplasms*
8.Molecular Characterization of the NF2 Gene in Korean Patients with Neurofibromatosis Type 2: A Report of Four Novel Mutations.
Moon Woo SEONG ; Im Kyung YEO ; Sung Im CHO ; Chul Kee PARK ; Seung Ki KIM ; Sun Ha PAEK ; Dong Gyu KIM ; Hee Won JUNG ; Hyunwoong PARK ; So Yeon KIM ; Ji Yeon KIM ; Sung Sup PARK
The Korean Journal of Laboratory Medicine 2010;30(2):190-194
BACKGROUND: Neurofibromatosis type 2 (NF2) is an autosomal dominant syndrome caused by the NF2 tumor suppressor gene. However, the NF2 mutation characteristics in Korean patients are not sufficiently understood. In this study, we conducted a comprehensive mutational analysis in 7 Korean NF2 patients by performing direct sequencing and gene-dosage assessment. METHODS: We analyzed all exons and flanking regions of NF2 by direct sequencing and screened the deletions or duplications involving NF2 by multiplex ligation-dependent probe amplification. RESULTS: Four novel NF2 mutations, including 2 splice-site mutations (c.364-1G>A and c.886-3C>G), 1 frameshift mutation (c.524delA), and 1 missense mutation (c.397T>C; p.Cys133Arg), were identified in our patients. No large deletion or duplication was identified in our series. Subsequently, we identified an abnormal splicing product by using reverse transcription-PCR and direct sequencing in 2 patients with a novel splice-site mutation. The missense mutation c.397T>C was predicted to have harmful effects on protein function. CONCLUSIONS: The detection rate of NF2 mutations in Korean patients (57%) is similar to those in other populations. Our results provided a greater insight into the mutational spectrum of the NF2 gene in Korean subjects.
3' Flanking Region/genetics
;
5' Flanking Region/genetics
;
Adult
;
Aged
;
Amino Acid Sequence
;
Asian Continental Ancestry Group/*genetics
;
Child, Preschool
;
Exons
;
Female
;
Frameshift Mutation
;
*Genes, Neurofibromatosis 2
;
Humans
;
Male
;
Middle Aged
;
Molecular Sequence Data
;
*Mutation
;
Mutation, Missense
;
Neurofibromatosis 2/diagnosis/*genetics
;
RNA Splice Sites
;
Republic of Korea
;
Sequence Analysis, DNA
;
Young Adult
9.The Use of Medical Devices for Medical Skin Care and the Legal Issues.
Un Cheol YEO ; Chan Woo JEONG ; Seung Kyung HANN ; Hong Jig KIM ; Eul Nam HAN ; Ki Beom PARK ; Kwang Ho CHOI ; Hae Soo MOK ; Byung Chun MOON ; Yong Sang KIM ; Sung Woo CHOI ; Seon Young HWANG ; Ee Seok LIM ; Bang Soon KIM ; Suk Min KIM ; Hyung Ju KIM ; Hae Shin CHUNG ; Kyung Sik MIN ; Sang Jun LEE ; Seung Hoon CHA ; Suk Joo CHOI ; Jae Hong SHIM ; Geun Soo LEE ; Pok Kee MIN ; Ji Hwan HWANG ; Chang Hun HUH
Korean Journal of Dermatology 2009;47(11):1236-1245
BACKGROUND: Medical skin care is essential for the treatment of skin diseases all over the world. Medical skin care is also part of medical practice and this must be differentiated from the simple skin care that is given for normal healthy skin. OBJECTIVE: We wanted to discuss medical skin care and the related medical devices and legal issues. METHODS: We reviewed the related laws and regulations, we consulted experts and associations and we analyzed the result of the survey. RESULTS: Legally, medical skin care and simple skin care are well classified. However, many illegal procedures are still performed by non-medical personnel and many adverse effects have been reported as a result. Furthermore, there are no legal restrictions for the performer based on the grade of each medical skin care procedure. CONCLUSION: For the best results and safe procedures, medical skin care must be performed by approved medical equipment under the supervision of a physician or medical personnel. Continuous control and guidance by the government is strongly needed.
Jurisprudence
;
Organization and Administration
;
Skin
;
Skin Care
;
Skin Diseases
;
Social Control, Formal
10.Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial
Jie-Eun LEE ; Seung Hee YU ; Sung Rae KIM ; Kyu Jeung AHN ; Kee-Ho SONG ; In-Kyu LEE ; Ho-Sang SHON ; In Joo KIM ; Soo LIM ; Doo-Man KIM ; Choon Hee CHUNG ; Won-Young LEE ; Soon Hee LEE ; Dong Joon KIM ; Sung-Rae CHO ; Chang Hee JUNG ; Hyun Jeong JEON ; Seung-Hwan LEE ; Keun-Young PARK ; Sang Youl RHEE ; Sin Gon KIM ; Seok O PARK ; Dae Jung KIM ; Byung Joon KIM ; Sang Ah LEE ; Yong-Hyun KIM ; Kyung-Soo KIM ; Ji A SEO ; Il Seong NAM-GOONG ; Chang Won LEE ; Duk Kyu KIM ; Sang Wook KIM ; Chung Gu CHO ; Jung Han KIM ; Yeo-Joo KIM ; Jae-Myung YOO ; Kyung Wan MIN ; Moon-Kyu LEE
Diabetes & Metabolism Journal 2024;48(4):730-739
Background:
It is well known that a large number of patients with diabetes also have dyslipidemia, which significantly increases the risk of cardiovascular disease (CVD). This study aimed to evaluate the efficacy and safety of combination drugs consisting of metformin and atorvastatin, widely used as therapeutic agents for diabetes and dyslipidemia.
Methods:
This randomized, double-blind, placebo-controlled, parallel-group and phase III multicenter study included adults with glycosylated hemoglobin (HbA1c) levels >7.0% and <10.0%, low-density lipoprotein cholesterol (LDL-C) >100 and <250 mg/dL. One hundred eighty-five eligible subjects were randomized to the combination group (metformin+atorvastatin), metformin group (metformin+atorvastatin placebo), and atorvastatin group (atorvastatin+metformin placebo). The primary efficacy endpoints were the percent changes in HbA1c and LDL-C levels from baseline at the end of the treatment.
Results:
After 16 weeks of treatment compared to baseline, HbA1c showed a significant difference of 0.94% compared to the atorvastatin group in the combination group (0.35% vs. −0.58%, respectively; P<0.0001), whereas the proportion of patients with increased HbA1c was also 62% and 15%, respectively, showing a significant difference (P<0.001). The combination group also showed a significant decrease in LDL-C levels compared to the metformin group (−55.20% vs. −7.69%, P<0.001) without previously unknown adverse drug events.
Conclusion
The addition of atorvastatin to metformin improved HbA1c and LDL-C levels to a significant extent compared to metformin or atorvastatin alone in diabetes and dyslipidemia patients. This study also suggested metformin’s preventive effect on the glucose-elevating potential of atorvastatin in patients with type 2 diabetes mellitus and dyslipidemia, insufficiently controlled with exercise and diet. Metformin and atorvastatin combination might be an effective treatment in reducing the CVD risk in patients with both diabetes and dyslipidemia because of its lowering effect on LDL-C and glucose.